SCHEMBL27436652

SCHEMBL27436652

c1cc2c(c(N3CCC4(CC3)COC4)c1)CCN2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
DRD2 P14416 4/20 0.40
HTR1A P08908 1/20 0.40
CRBN Q96SW2 1/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
PDE9A O76083 1/20 0.32
CYP2D6 P10635 3/20 0.32
USP2 O75604 2/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
CYP3A4 P08684 2/20 0.31
TSHR P16473 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30047448 0.81 DRD2 (0.43) DRD2HTR1ACRBNMEN1ALDH1A1
SCHEMBL15311796 0.81 DRD2 (0.43) DRD2HTR1ACRBNMEN1ALDH1A1
SCHEMBL26954410 0.81 DRD2 (0.40) DRD2HTR1ACRBNHCRTR1HCRTR2
Hydrochloric Acid SCHEMBL23403776 0.80 DRD2 (0.43) DRD2HTR1ACRBNMEN1ALDH1A1
Hydrochloric Acid SCHEMBL29974676 0.80 DRD2 (0.43) DRD2HTR1ACRBNMEN1ALDH1A1
Hydrochloric Acid SCHEMBL23045207 0.80 DRD2 (0.43) DRD2HTR1ACRBNMEN1ALDH1A1
SCHEMBL28241594 0.79 DRD2 (0.49) DRD2HTR1ACYP2D6DRD3TSHR
SCHEMBL6772080 0.77 ADRB1 (0.49) DRD2HTR1ACYP2D6DRD3TSHR
SCHEMBL21646391 0.77 DRD2 (0.48) DRD2HTR1ACYP2D6DRD3TSHR
Hydrochloric Acid SCHEMBL28808104 0.76 DRD2 (0.47) DRD2HTR1AALDH1A1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024133499-A1 GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) 2024-06-27 WO disclosed